Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes
(2021) In Human Immunology 82(12). p.976-981- Abstract
Dendritic cells (DCs) with capacity of antigen cross-presentation are of key interest for immunotherapy against cancer as they can induce antigen-specific cytotoxic T lymphocyte (CTL) responses. This study describes frequencies of DC subtypes in human tonsils and lymph nodes, and phenotypic aspects that may be targeted by adjuvant measures. From human tonsils and neck lymph nodes, DCs were identified through flow cytometry, and subsets of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) were investigated. Maturity status was assessed and surface receptors with CTL-promoting potentials were studied. CD123+ pDCs as well as CD1c+, CD141+, and CD1c-CD141- mDCs were detected in tonsils and... (More)
Dendritic cells (DCs) with capacity of antigen cross-presentation are of key interest for immunotherapy against cancer as they can induce antigen-specific cytotoxic T lymphocyte (CTL) responses. This study describes frequencies of DC subtypes in human tonsils and lymph nodes, and phenotypic aspects that may be targeted by adjuvant measures. From human tonsils and neck lymph nodes, DCs were identified through flow cytometry, and subsets of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) were investigated. Maturity status was assessed and surface receptors with CTL-promoting potentials were studied. CD123+ pDCs as well as CD1c+, CD141+, and CD1c-CD141- mDCs were detected in tonsils and lymph nodes. Both sites featured a similar presence of DC subsets, with CD123+ pDC being dominant and CD141+ mDCs least frequent. Based on CD80/CD86 expression, all DC subtypes featured a low degree of maturation. Expression of pattern recognition receptors (PRRs) CD206, CD207, DC-SIGN, TLR2, and TLR4, as well as the chemokine receptor XCR1, indicated DC subset-specific receptor profiles. We conclude that tonsils and lymph nodes share common features in terms of DC subset frequency and maturation as well as PRR and XCR1 expression pattern. Our work suggests that both sites may be considered for vaccine deposition in DC-mediated immunotherapy.
(Less)
- author
- Askmyr, David
LU
; Abolhalaj, Milad
LU
; Gomez Jimenez, David
LU
; Greiff, Lennart
LU
; Lindstedt, Malin
LU
and Lundberg, Kristina LU
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cancer, Dendritic cell, Immunotherapy, PRR, Vaccination
- in
- Human Immunology
- volume
- 82
- issue
- 12
- pages
- 976 - 981
- publisher
- Elsevier
- external identifiers
-
- pmid:34511272
- scopus:85114695570
- ISSN
- 0198-8859
- DOI
- 10.1016/j.humimm.2021.08.007
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2021 The Authors
- id
- fbf5460b-6b83-47d8-a977-a3a7896fee5b
- date added to LUP
- 2021-10-13 13:49:27
- date last changed
- 2025-01-13 15:11:03
@article{fbf5460b-6b83-47d8-a977-a3a7896fee5b, abstract = {{<p>Dendritic cells (DCs) with capacity of antigen cross-presentation are of key interest for immunotherapy against cancer as they can induce antigen-specific cytotoxic T lymphocyte (CTL) responses. This study describes frequencies of DC subtypes in human tonsils and lymph nodes, and phenotypic aspects that may be targeted by adjuvant measures. From human tonsils and neck lymph nodes, DCs were identified through flow cytometry, and subsets of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) were investigated. Maturity status was assessed and surface receptors with CTL-promoting potentials were studied. CD123<sup>+</sup> pDCs as well as CD1c<sup>+</sup>, CD141<sup>+</sup>, and CD1c<sup>-</sup>CD141<sup>-</sup> mDCs were detected in tonsils and lymph nodes. Both sites featured a similar presence of DC subsets, with CD123<sup>+</sup> pDC being dominant and CD141<sup>+</sup> mDCs least frequent. Based on CD80/CD86 expression, all DC subtypes featured a low degree of maturation. Expression of pattern recognition receptors (PRRs) CD206, CD207, DC-SIGN, TLR2, and TLR4, as well as the chemokine receptor XCR1, indicated DC subset-specific receptor profiles. We conclude that tonsils and lymph nodes share common features in terms of DC subset frequency and maturation as well as PRR and XCR1 expression pattern. Our work suggests that both sites may be considered for vaccine deposition in DC-mediated immunotherapy.</p>}}, author = {{Askmyr, David and Abolhalaj, Milad and Gomez Jimenez, David and Greiff, Lennart and Lindstedt, Malin and Lundberg, Kristina}}, issn = {{0198-8859}}, keywords = {{Cancer; Dendritic cell; Immunotherapy; PRR; Vaccination}}, language = {{eng}}, number = {{12}}, pages = {{976--981}}, publisher = {{Elsevier}}, series = {{Human Immunology}}, title = {{Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes}}, url = {{http://dx.doi.org/10.1016/j.humimm.2021.08.007}}, doi = {{10.1016/j.humimm.2021.08.007}}, volume = {{82}}, year = {{2021}}, }